Originally developed for type 2 diabetes and weight management, the GLP-1/GIP medication tirzepatide under the brand name Zepbound is now FDA-approved to treat obstructive sleep apnea
Prescription & Pharmacy Processing If approved, your prescription will be issued and sent directly to our compounding pharmacy, where your medication will begin processing
Definitely interesting
Clinical studies show that moderate doses of semaglutide are effective for weight management at 3 and 6 months when combined with lifestyle modifications such as a healthy diet, meal tracking, portion control advice, psychosocial support, and physical activity coaching
[18] [19] Situations where dose escalation should be deferred include: persistent gastrointestinal symptoms that haven't resolved, history of severe hypersensitivity reactions, acute pancreatitis during treatment, or patient preference to remain at current dose
Overall, tirzepatide was found to be safe and well-tolerated, with only minor reports of gastrointestinal adverse effects [10]